Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

Seneca Biopharma, Germantown, Md., issued a press release announcing its recent meeting with the FDA to discuss elements of a final design and protocol for a Phase 3 trial investigating…

Continue Reading Seneca Biopharma Preparing for its Phase 3 Trial to Test NSI-566 for Amyotrophic Lateral Sclerosis

Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers

A recent study, conducted my Melinda Kavanaugh from the University of Wisconsin, Milwaukee, examined the role of children who are acting as caregivers for those diagnosed with amyotrophic lateral sclerosis…

Continue Reading Study Highlights Need to Support Youth Acting as Amyotrophic Lateral Sclerosis Caregivers
Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
source: pixabay.com

Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy

  Advances in medicine have been responsible for longer overall survival in patients with neurodegenerative-neuromuscular diseases. According to a recent report in RTMagazine, an increase in the number of patients…

Continue Reading Neurodegenerative-Neuromuscular Diseases and Airway Clearance Therapy
He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS
source: pixabay.com

He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS

As originally reported in ArcaMax,  when you get a diagnosis for a terminal rare disease, a wave of emotions crashes over life. Brian Wallach emerged clutching 'hope.' In 2017, Brian,…

Continue Reading He Didn’t Want to Miss his Daughter’s First Birthday, so he Campaigned for a Cure for ALS
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
source: pixabay.com

AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS

  AI Therapeutics is a biotechnology company that uses artificial intelligence to match drugs to indications. They do so through the use of their algorithm, Guardian Angel. This algorithm has…

Continue Reading AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden
source: pixabay.com

A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden

According to a story from ALS News Today, the nation of Sweden is starting to emerge as a leader for amyotrophic lateral sclerosis (ALS) research in Europe. This is mostly…

Continue Reading A Patient and Scientist Join Forces to Spur Amyotrophic Lateral Sclerosis Research in Sweden

New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

A team of cross-disciplinary researchers at Arizona State University (ASU) is working to develop a software which patients with neurological disorders may easily use to assess their disease progression. Through…

Continue Reading New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level

  The University of Southern California (USC) recently published an article in USC News announcing that researchers have discovered a technique allowing them to untangle the coiled, spiraling DNA molecules.…

Continue Reading Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level
Life of Jewish Amyotrophic Lateral Sclerosis Patient Who Defied the Odds Celebrated in Documentary
source: pixabay.com

Life of Jewish Amyotrophic Lateral Sclerosis Patient Who Defied the Odds Celebrated in Documentary

According to a story from The Times of Israel, Jenni Kleinman Berebitsky died the past August at age 43 due to complications of amyotrophic lateral sclerosis (ALS). The woman was…

Continue Reading Life of Jewish Amyotrophic Lateral Sclerosis Patient Who Defied the Odds Celebrated in Documentary
Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial
DarkoStojanovic / Pixabay

Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company Collaborative Medicinal Development, LLC has recently announced that the first patient has been enrolled in a clinical trial that will test…

Continue Reading Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial